Off-label Use of Valproate in Anxiety Disorders

Some evidence from preclinical and clinical studies suggests that valproate may have therapeutic effects in the treatment of anxiety disorders.We reviewed the existing literature on the efficacy of valproate in the treatment of these psychiatric disorders.

Authors

Institutions

Publication Details

Journal
Swiss Archives of Neurology Psychiatry and Psychotherapy
Published
2024-08-15
DOI
https://doi.org/10.4414/sanp.2024.1362827258
Primary Topic
Pharmaceutical studies and practices
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Off-label Use of Valproate in Anxiety Disorders

Calogero Crapanzano, Ilaria Casolaro, Andrea Politano, Chiara Amendola
Swiss Archives of Neurology Psychiatry and Psychotherapy
Pharmaceutical studies and practices
article

Off-label Use of Valproate in Anxiety Disorders

Calogero Crapanzano, Ilaria Casolaro, Andrea Politano, Chiara Amendola
article en

Abstract

Some evidence from preclinical and clinical studies suggests that valproate may have therapeutic effects in the treatment of anxiety disorders.We reviewed the existing literature on the efficacy of valproate in the treatment of these psychiatric disorders.

Swiss Archives of Neurology Psychiatry and Psychotherapy
Azienda Socio Sanitaria Territoriale Lariana (IT), Azienda Usl Toscana Centro (IT)
Openalex Percentile: Top 80%
Pharmaceutical studies and practices
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.